| EPO |
P01588
|
erythropoietin
|
|
1.1E-02 |
0.381 |
0.885 |
| JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
| MMP1 |
P03956
|
matrix metallopeptidase 1
|
Enzyme
|
7.7E-18 |
0.385 |
0.885 |
| CD14 |
P08571
|
CD14 molecule
|
|
4.9E-05 |
0.392 |
0.885 |
| IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |
| KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |
| MAPK8 |
P45983
|
mitogen-activated protein kinase 8
|
Kinase
|
1.00 |
0.397 |
0.885 |
| RELA |
Q04206
|
RELA proto-oncogene, NF-kB subunit
|
Transcription factor
|
1.00 |
0.406 |
0.885 |
| THBS1 |
P07996
|
thrombospondin 1
|
|
1.00 |
0.407 |
0.885 |
| CD38 |
P28907
|
CD38 molecule
|
Enzyme
|
2.3E-06 |
0.407 |
0.885 |
| NCAM1 |
P13591
|
neural cell adhesion molecule 1
|
|
1.00 |
0.415 |
0.885 |
| ABCG2 |
Q9UNQ0
|
ATP binding cassette subfamily G member 2 (Junior blood group)
|
Transporter
|
2.1E-32 |
0.419 |
0.885 |
| BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
| FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
| HSPA9 |
P38646
|
heat shock protein family A (Hsp70) member 9
|
|
0.97 |
0.502 |
0.885 |
| H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| MECP2 |
P51608
|
methyl-CpG binding protein 2
|
Epigenetic regulator
|
0.89 |
0.414 |
0.846 |
| BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
| TBC1D9 |
Q6ZT07
|
TBC1 domain family member 9
|
Enzyme
|
2.8E-05 |
0.399 |
0.846 |
| WNK1 |
Q9H4A3
|
WNK lysine deficient protein kinase 1
|
Kinase
|
1.00 |
0.416 |
0.846 |
| SYT1 |
P21579
|
synaptotagmin 1
|
Transporter
|
0.60 |
0.412 |
0.846 |
| FLT1 |
P17948
|
fms related receptor tyrosine kinase 1
|
Kinase
|
1.00 |
0.419 |
0.846 |
| HFE |
Q30201
|
homeostatic iron regulator
|
|
2.6E-08 |
0.436 |
0.846 |
| ISG20 |
Q96AZ6
|
interferon stimulated exonuclease gene 20
|
|
2.9E-03 |
0.414 |
0.846 |